Prevalence and treatment of active asthma in Scotland using the prescribing information system

M F C Steiner, G Devereux, S W Turner, J McLay, I Bishop, G Wyper

Research output: Contribution to journalAbstract

81 Citations (Scopus)

Abstract

Background Many studies of the clinical epidemiology of asthma that have used routinely collected drug prescription or dispensing data have been limited to samples assumed to be representative of the national population from which they are drawn. Our aim was to describe asthma prevalence and treatment in children and young adults using the Prescribing Information System (PIS), a national prescribing and dispensing database for Scotland.

Methods For more than 95% of the dispensed prescriptions in primary care between December 2009 and November 2011 a valid patient identifier was available and the database includes some socio-demographical characteristics (age-group, sex, SIMD) of the patients. Data were also linked to hospital admission data. The analysis was limited to patients aged up to 44 years to reduce contamination by COPD.

Data

We identified 358,804 patients with 2,809,563 dispensed prescriptions for inhaled therapies used for asthma; equating to a prevalence of 11.4% of the 3,139,356 people aged 0–44 registered with a GP in Scotland. The age specific prevalence rates are detailed in the table. However, 95,207 patients had only one or two dispensed prescriptions for short-acting beta2-agonists (SABA) and no other inhaled therapies in the two years; we consider these patients to be unlikely to have active asthma (table). Additionally, 1,041 cases on inhaled therapy had hospital admission(s) with a diagnosis of COPD (ICD10: J40-J44) and are excluded from further analysis. 6,056 (2.3%) of people collecting inhaled therapy (>2 SABA) had at least one hospital admission with a primary diagnosis of asthma.
Original languageEnglish
Pages (from-to)A185-A186
Number of pages2
JournalThorax
Volume67
Issue numberSuppl. 2
DOIs
Publication statusPublished - Dec 2012
EventWinter Meeting of the British-Thoracic-Society 2012 - London
Duration: 5 Dec 20127 Dec 2012

Cite this

Prevalence and treatment of active asthma in Scotland using the prescribing information system. / Steiner, M F C; Devereux, G; Turner, S W; McLay, J; Bishop, I; Wyper, G.

In: Thorax, Vol. 67, No. Suppl. 2, 12.2012, p. A185-A186.

Research output: Contribution to journalAbstract

Steiner, M F C ; Devereux, G ; Turner, S W ; McLay, J ; Bishop, I ; Wyper, G. / Prevalence and treatment of active asthma in Scotland using the prescribing information system. In: Thorax. 2012 ; Vol. 67, No. Suppl. 2. pp. A185-A186.
@article{edb22a4c353143ae949df1614acbaa45,
title = "Prevalence and treatment of active asthma in Scotland using the prescribing information system",
abstract = "Background Many studies of the clinical epidemiology of asthma that have used routinely collected drug prescription or dispensing data have been limited to samples assumed to be representative of the national population from which they are drawn. Our aim was to describe asthma prevalence and treatment in children and young adults using the Prescribing Information System (PIS), a national prescribing and dispensing database for Scotland.Methods For more than 95{\%} of the dispensed prescriptions in primary care between December 2009 and November 2011 a valid patient identifier was available and the database includes some socio-demographical characteristics (age-group, sex, SIMD) of the patients. Data were also linked to hospital admission data. The analysis was limited to patients aged up to 44 years to reduce contamination by COPD.DataWe identified 358,804 patients with 2,809,563 dispensed prescriptions for inhaled therapies used for asthma; equating to a prevalence of 11.4{\%} of the 3,139,356 people aged 0–44 registered with a GP in Scotland. The age specific prevalence rates are detailed in the table. However, 95,207 patients had only one or two dispensed prescriptions for short-acting beta2-agonists (SABA) and no other inhaled therapies in the two years; we consider these patients to be unlikely to have active asthma (table). Additionally, 1,041 cases on inhaled therapy had hospital admission(s) with a diagnosis of COPD (ICD10: J40-J44) and are excluded from further analysis. 6,056 (2.3{\%}) of people collecting inhaled therapy (>2 SABA) had at least one hospital admission with a primary diagnosis of asthma.",
author = "Steiner, {M F C} and G Devereux and Turner, {S W} and J McLay and I Bishop and G Wyper",
year = "2012",
month = "12",
doi = "10.1136/thoraxjnl-2012-202678.367",
language = "English",
volume = "67",
pages = "A185--A186",
journal = "Thorax",
issn = "0040-6376",
publisher = "BMJ Publishing Group Ltd",
number = "Suppl. 2",

}

TY - JOUR

T1 - Prevalence and treatment of active asthma in Scotland using the prescribing information system

AU - Steiner, M F C

AU - Devereux, G

AU - Turner, S W

AU - McLay, J

AU - Bishop, I

AU - Wyper, G

PY - 2012/12

Y1 - 2012/12

N2 - Background Many studies of the clinical epidemiology of asthma that have used routinely collected drug prescription or dispensing data have been limited to samples assumed to be representative of the national population from which they are drawn. Our aim was to describe asthma prevalence and treatment in children and young adults using the Prescribing Information System (PIS), a national prescribing and dispensing database for Scotland.Methods For more than 95% of the dispensed prescriptions in primary care between December 2009 and November 2011 a valid patient identifier was available and the database includes some socio-demographical characteristics (age-group, sex, SIMD) of the patients. Data were also linked to hospital admission data. The analysis was limited to patients aged up to 44 years to reduce contamination by COPD.DataWe identified 358,804 patients with 2,809,563 dispensed prescriptions for inhaled therapies used for asthma; equating to a prevalence of 11.4% of the 3,139,356 people aged 0–44 registered with a GP in Scotland. The age specific prevalence rates are detailed in the table. However, 95,207 patients had only one or two dispensed prescriptions for short-acting beta2-agonists (SABA) and no other inhaled therapies in the two years; we consider these patients to be unlikely to have active asthma (table). Additionally, 1,041 cases on inhaled therapy had hospital admission(s) with a diagnosis of COPD (ICD10: J40-J44) and are excluded from further analysis. 6,056 (2.3%) of people collecting inhaled therapy (>2 SABA) had at least one hospital admission with a primary diagnosis of asthma.

AB - Background Many studies of the clinical epidemiology of asthma that have used routinely collected drug prescription or dispensing data have been limited to samples assumed to be representative of the national population from which they are drawn. Our aim was to describe asthma prevalence and treatment in children and young adults using the Prescribing Information System (PIS), a national prescribing and dispensing database for Scotland.Methods For more than 95% of the dispensed prescriptions in primary care between December 2009 and November 2011 a valid patient identifier was available and the database includes some socio-demographical characteristics (age-group, sex, SIMD) of the patients. Data were also linked to hospital admission data. The analysis was limited to patients aged up to 44 years to reduce contamination by COPD.DataWe identified 358,804 patients with 2,809,563 dispensed prescriptions for inhaled therapies used for asthma; equating to a prevalence of 11.4% of the 3,139,356 people aged 0–44 registered with a GP in Scotland. The age specific prevalence rates are detailed in the table. However, 95,207 patients had only one or two dispensed prescriptions for short-acting beta2-agonists (SABA) and no other inhaled therapies in the two years; we consider these patients to be unlikely to have active asthma (table). Additionally, 1,041 cases on inhaled therapy had hospital admission(s) with a diagnosis of COPD (ICD10: J40-J44) and are excluded from further analysis. 6,056 (2.3%) of people collecting inhaled therapy (>2 SABA) had at least one hospital admission with a primary diagnosis of asthma.

U2 - 10.1136/thoraxjnl-2012-202678.367

DO - 10.1136/thoraxjnl-2012-202678.367

M3 - Abstract

VL - 67

SP - A185-A186

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - Suppl. 2

ER -